ANI Pharmaceuticals | Betriebsaufwand



Operating Expenses Veränderung Datum
AbbVie USD 16.59B 5.96B 2024-12
ANI Pharmaceuticals USD 194.95M 211M 2024-12
Aurora Cannabis CAD 51.98M 31.53M 2024-12
Canopy Growth CAD 98.58M 10.03M 2024-12
Eli Lilly USD 8.38B 1.53B 2024-12
Hikma Pharmaceutical USD 1.24B 87M 2024-06
Knight Therapeutics CAD 89.06M 2.02M 2024-09
Novartis USD 10.15B 579M 2024-12
Perrigo USD 1.03B 13.4M 2024-12
Sun Pharmaceuticals INR 104.3B 3.51B 2024-12
Teva Pharmaceutical Industries USD 3.77B 609M 2024-12



ANI Pharmaceuticals Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.